ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0634

Correlation Between the Functional Component of the Multidimensional Health Assessment Questionnaire (FN), Modified Health Assessment Questionnaire (MHAQ), Health Assessment Questionnaire II (HAQ-II) and a Single Functional Question (PF) in Patients with Rheumatic Disease

Andrea Healy1, Johny Fares1, Martin Bergman2, Kaleb Michaud3, Alison Petro3 and Harlan Sayles3, 1Main Line Health, Wynnewood, PA, 2Martin Jan Bergman, MD, Ridley Park, PA, 3University of Nebraska Medical Center, Omaha, NE

Meeting: ACR Convergence 2021

Keywords: autoimmune diseases, Disability, functional status, Quality Indicators, quality of life

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 7, 2021

Title: Measures & Measurement of Healthcare Quality Poster (0623–0659)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: There has been significant work developing questionnaires to find effective and reliable ways of characterizing the functional status of patients, to track disease progression and to measure response to treatment. However, these are often lengthy and difficult to perform, especially via telemedicine. We studied whether a VAS response (0-10) to a single question (Physical Function: “PF”): “We are interested in learning how your disease is affecting your ability to function in daily life” could replace the MDHAQ-FN (FN), MHAQ, HAQ-II to reliably predict the functional status of patients with rheumatic disease.

Methods: Pertinent data for adult patients with rheumatic disease collected as part of the routine practices from both a single private practice and an academic site was reviewed. Patients were asked to complete the MHAQ, FN, HAQ-II, and the single question. MHAQ is composed of 8 ADL items. FN is the functional component of the MDHAQ composed of the MHAQ plus 2 additional items. HAQ-II is composed of 10 ADL items. MHAQ, FN, and HAQ-II are scored by taking the mean item score, range 0-3. Spearman’s correlations were used to compare scores from the MHAQ, FN, HAQ-II and the PF. All calculations were performed using Stata Software v14 (Plano TX). IRB approval was obtained.

Results: 1,298 patients (29% male, mean age = 60.87 years, mean disease duration 8.7 = years) were analyzed. Patient characteristics are presented in table 1. The FN, MHAQ and HAQ-II all had a very strong correlation to each other. The PF correlated strongly to scores of the FN, MHAQ and HAQ-II (Table 1.1). These correlations were generally maintained, regardless of the underlying diagnosis. Similar results were found at the UNMC.

Conclusion: This study demonstrates the utility of the PF: “We are interested in learning how your disease is affecting your ability to function in daily life” as a substitute for the FN, MHAQ and HAQ-II, questionnaires that have previously been validated as effective measures of functional status. The results were comparable, regardless of the underlying diagnosis. This single question is quick to administer and easy to score. In a time when telemedicine is becoming more prevalent, finding efficient and reliable ways of monitoring patients’ wellbeing has become more important than ever. Incorporating this single question into general rheumatologic practice, in conjunction with other clinical tools, such as physical exam and lab values, can help streamline the collection of important data without sacrificing quality of care.

Table 1 – Pooled Data: Patient Characteristics

Table 1.1 – Spearman’s correlation scores


Disclosures: A. Healy, None; J. Fares, None; M. Bergman, AbbVie, 2, 6, Amgen Inc., 6, Novartis, 2, 6, Pfizer, 2, 6, Sanofi, 2, 6, Bristol Myers Squibb, 2, Celgene, 2, Genentech, 2, Janssen, 2, Merck, 2, Johnson & Johnson, 11, Sandoz, 1, GSK, 6, Scipher, 2; K. Michaud, None; A. Petro, None; H. Sayles, None.

To cite this abstract in AMA style:

Healy A, Fares J, Bergman M, Michaud K, Petro A, Sayles H. Correlation Between the Functional Component of the Multidimensional Health Assessment Questionnaire (FN), Modified Health Assessment Questionnaire (MHAQ), Health Assessment Questionnaire II (HAQ-II) and a Single Functional Question (PF) in Patients with Rheumatic Disease [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/correlation%e2%80%afbetween%e2%80%afthe-functional-component-of-the-multidimensional-health-assessment-questionnaire%e2%80%affn-modified-health-assessment-questionnaire%e2%80%afmhaq-health-asses/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlation%e2%80%afbetween%e2%80%afthe-functional-component-of-the-multidimensional-health-assessment-questionnaire%e2%80%affn-modified-health-assessment-questionnaire%e2%80%afmhaq-health-asses/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology